Joel Lewis, President and CEO at GALECTIN THERAPEUTICS INC (GALT), bought 1,000 shares at $1.52 ($2K) on 2023-02-16, disclosed to the SEC on 2023-02-21.
Seasonal purchase ($2k) by President and CEO — this insider has traded GALT in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| GALT | SELL | 2025-11-19 | $231K | — | Filing → |
| GALT | SELL | 2025-11-12 | $11K | — | Filing → |
| GALT | SELL | 2025-11-07 | $1K | — | Filing → |